We’ve received a 19.9m NOK grant from KLINBEFORSK
We’ve received a 19.9 million NOK funding from KLINBEFORSK for developing CRISPR-Cas9 gene therapy for STAT1 Gain-of-Function disease.
Home » News
Catch up on the latest news about what we’ve been up to and what’s happening at Haapaniemi Lab, including new job openings, research updates, new publications and team events.
We’ve received a 19.9 million NOK funding from KLINBEFORSK for developing CRISPR-Cas9 gene therapy for STAT1 Gain-of-Function disease.
We are very proud to be part of Precision Immunotherapy Alliance “PRIMA”, a new Center of Excellence recently founded by The Research Council of Norway!
Pavel Kopcil attended the eight annual meeting on Genome engineering: CRISPR Frontiers at Cold Spring Harbor Laboratory in New York.
We’ve won the European Genomics Grant from Standard BioTools! As the prize we will have the C1 system from Standard BioTools™ installed in our laboratory.
On 22nd of June, Jacob defended his master thesis “In vivo and in vitro strategies to study precise gene editing using CRISPR-Cas9”.
Aftenposten run a focused life science collection. Our laboratory was featured as representatives of NCMM in an article about new therapies for serious diseases in children.
In June, four master students joined our lab to participate in laboratory training in CRISPR gene editing.
Haapaniemi group participated in the NCMM scientific retreat in June. The retreat was held, for the first time in three years, in the beautiful Son Spa in Akershus.
Our PhD Student, Ganna, recently had her PhD thesis defence, and, of course, she passed with flying colours. Congratulations, Ganna! Ganna’s main project at Haapaniemi